Karbownik M, Lewiński A
Department of Thyroidology, University School of Medicine, Lódź, Poland.
Cytobios. 1994;80(322):133-43.
The effects of intravenous (i.v.) injections of vasoactive intestinal polypeptide (VIP) and intraperitoneal (i.p.) injections of thyroid-stimulating hormone (TSH, thyrotropin) on 3H-thymidine incorporation into the DNA of rat thyroid lobes incubated, after collecting, in vitro, were investigated. The animals of groups 1-6 were injected with the following substances: group 1, 0.9% NaCl; group 2, 2 IU TSH (i.p.); group 3, 10(-12) mol VIP; group 4, 10(-10) mol VIP; group 5, 10(-8) mol VIP; and group 6, 10(-8) mol VIP + 2 IU TSH (i.p.). The rats of each group were divided into three subgroups, and sacrificed after 6, 12 or 24 h from the time of injection. For group 1, the additional control group zero was used, and these controls were sacrificed immediately after i.v. injections of 0.9% NaCl at zero time. After decapitation the thyroid lobes were collected and then incubated for 4 h in RPMI 1640 medium in the presence of 3H-thymidine, 15% FCS and Hepes buffer. In all groups and at all times an increase of 3H-thymidine incorporation occurred; the stimulatory effect of VIP (in all doses) was stronger than that of TSH; the rate of 3H-thymidine incorporation after injections of both VIP and TSH (group 6), was higher than the rates following injections of VIP alone (group 5) or TSH alone (group 2).
研究了静脉注射血管活性肠肽(VIP)和腹腔注射促甲状腺激素(TSH,促甲状腺素)对体外收集的大鼠甲状腺叶DNA中3H-胸腺嘧啶核苷掺入的影响。1-6组动物注射以下物质:1组,0.9%氯化钠;2组,2国际单位促甲状腺激素(腹腔注射);3组,10^(-12)摩尔血管活性肠肽;4组,10^(-10)摩尔血管活性肠肽;5组,10^(-8)摩尔血管活性肠肽;6组,10^(-8)摩尔血管活性肠肽 + 2国际单位促甲状腺激素(腹腔注射)。每组大鼠分为三个亚组,在注射后6、12或24小时处死。对于1组,使用额外的零对照组,这些对照组在零时静脉注射0.9%氯化钠后立即处死。断头后收集甲状腺叶,然后在含有3H-胸腺嘧啶核苷、15%胎牛血清和Hepes缓冲液的RPMI 1640培养基中孵育4小时。在所有组和所有时间,3H-胸腺嘧啶核苷掺入均增加;血管活性肠肽(所有剂量)的刺激作用强于促甲状腺激素;同时注射血管活性肠肽和促甲状腺激素后(6组)的3H-胸腺嘧啶核苷掺入率高于单独注射血管活性肠肽(5组)或单独注射促甲状腺激素(2组)后的掺入率。